Identifying facility-level and infrastructure-level bottlenecks in Japan's lecanemab rollout through an online survey of dementia specialists. (PubMed, J Alzheimers Dis Rep) - Oct 16, 2026 - "Japan's rollout may be constrained by some bottlenecks in diagnostics, infusion infrastructure, and uncompensated tasks. Appropriate policy interventions might help secure equitable access to the treatment."
Journal • Alzheimer's Disease • CNS Disorders • Dementia • APOE
|
|
Ataru Igarashi; Atsushi Iwata; Haruhiko Akiyama; Kenichiro Sato; Kensaku Kasuga; Kiyotaka Nemoto; Manabu Ikeda; Ryoko Ihara; Saki Nakashima; Shinji Higashi; Shuichi Awata; Takeshi Iwatsubo; Tatsushi Toda; Tetsuaki Arai; Yoshiki Niimi
|